论文部分内容阅读
辅助性联合放、化疗加手术治疗已成为治疗局部宫颈浸润癌的一种新的有效方法。其中正确评估病变对放化疗的反应在制订手术方案中具有决定性作用。但目前常用的评估方法如麻醉后临床检查和CT检查可靠性较差,特别是难以将残瘤与放疗引起的炎症和纤维化区分。而MRI却能精确地将肿瘤与纤维化区别开。为确定MRI在评估宫颈癌对联合放化疗反应中的准确性,作者于1996年3月至1997年7月,对19例浸润局部宫颈的鳞癌病人进行了研究。其肾、肝、心、肺及凝血功能均正常,且无癌症手
Adjuvant radiotherapy, chemotherapy and surgery have become a new and effective method for the treatment of locally invasive cervical cancer. The correct assessment of the lesion response to radiotherapy and chemotherapy in the development of surgical programs have a decisive role. However, the commonly used assessment methods such as post-anesthesia clinical examination and CT examination have poor reliability, especially difficult to distinguish the inflammation and fibrosis caused by the residual tumor and radiotherapy. MRI can accurately distinguish tumors from fibrosis. To determine the accuracy of MRI in assessing cervical cancer response to combined chemoradiotherapy, the authors studied 19 patients with squamous cell carcinoma of the local cervix infiltrating from March 1996 to July 1997. The kidney, liver, heart, lung and blood coagulation are normal, and no cancer hand